Drawing for SEPTEC

USPTO serial 88237082

SEPTEC

Reviewed by CopyMark Law Group

Reg. 6082924Status 700Renewal
Filing date
Status date
Registration date
Jun 23, 2020
Examiner
KELLY, JOHN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SEPTEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J. O'Malley

John J. O'Malley VOLPE AND KOENIG, P.C.30 South 17th StreetSuite 1800Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical or veterinary purposes; diagnostic materials, namely, medical diagnostic immunoassays for testing body fluids for the presence of antigens and antibodies that are indicators of sepsis; diagnostic agents for medical use; diagnostic testing materials for medical use, namely, medical diagnostic test media in the form of liquid for measuring the presence of pathogen; medical diagnostic reagents and assays for testing of body fluids; chemical preparations for testing blood for medical purpose; none of the above-mentioned products being related to extracorporeal treatment of renal insufficiencyACTIVE—
010Medical diagnostic instruments for the analysis of body fluids; medical diagnostic instruments for testing for infections; tools for medical diagnostics, namely, medical diagnostic apparatuses for testing for infections; diagnostic, examination, and monitoring equipment for medical purposes, namely, the detection, diagnosis, and treatment of sepsis causing pathogens; diagnostic apparatus for medical purposes, namely, the detection of sepsis causing pathogens; diagnostic instruments for medical use, namely, for testing pathogen levels; testing instruments for medical diagnostic purposes, namely, medical diagnostic apparatus for testing pathogen levels in body fluids; medical diagnostic apparatus for medical purposes for testing pathogen levels in body fluids; sensor apparatus for medical use in diagnosis; spectrum analyzers for use in medical diagnosis; apparatus for carrying out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for testing pathogen levels in body fluids; medical diagnostic testing apparatus for use in immunoassay procedures; medical diagnostic testing instruments, namely, medical diagnostic apparatus for use in immunoassay procedures; electric instruments for medical use in the diagnosis of blood; blood testing apparatus; blood testing equipment, namely, blood collecting and sampling tubes; apparatus for blood analysis; apparatus for taking blood samples; apparatus for blood monitoring, namely, blood pressure monitors and blood oxygen monitors; apparatus for blood tests; none of the abovementioned products being related to extracorporeal treatment of renal insufficiencyACTIVE—
042Design and development of medical diagnostic apparatus; Research and development in the field of diagnostic preparations; Design and development of diagnostic apparatus; Design of diagnostic apparatus and equipment; Development of diagnostic apparatus; Design of diagnostic apparatus; Computer aided diagnostic testing services; Computer diagnostic services; Blood analysis services; Blood analysis services for scientific research purposes; none of the above mentioned services being related to extracorporeal treatment of renal insufficiencyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 23, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 5, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 4, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 4, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 4, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 22, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 28, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 28, 2019ALIEASSIGNED TO LIE—
Mar 22, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 22, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 15, 2019DOCKASSIGNED TO EXAMINER—
Jan 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance